Dendrite gets largest contract ever with SmithKline Beecham:
MORRISTOWN, N.J.--(BW HealthWire)--Oct. 15, 1997--Dendrite International, Inc. (NASDAQ/NMS:DRTE), the leading supplier of enterprise-wide customer management solutions, today announced that is has signed a definitive software agreement with SmithKline Beecham Pharmaceuticals, the largest operating unit of SmithKline Beecham. SmithKline Beecham has purchased Dendrite's Series 6 licenses to upgrade their representatives and managers from a competitor's DOS-based system.
This agreement is Dendrite's largest single one-time U.S. license agreement to date. Dendrite has licensed over 20,000 users on its Windows product since it was introduced in 1994. Today it is the most widely used sales effectiveness and management product in the pharmaceutical industry worldwide.
About Dendrite
In 17 countries worldwide, Dendrite International, Inc. provides comprehensive solutions used to manage, coordinate and control the activities of large sales organizations in complex selling environments. The Company offers modular software and custom-tailored support services that are designed to enhance the effectiveness of large teams of sales representatives and their managers by converting massive amounts of data into actionable information.
Dendrite has two major divisions: the Healthcare Division, which is the largest provider of customer management systems to the global pharmaceutical industry; and the Consumer Business Division, which serves the over-the-counter drug, cosmetics and consumer packaged goods industries worldwide.
Headquartered in Morristown, New Jersey, Dendrite employs over 600 people in 12 offices around the world. For more information, see the company's web site: drte.com.
This press release may contain forward-looking statements that may be viewed as predicting future events or outcomes with respect to Dendrite and its business. The predictions embodied in these statements will involve risks and uncertainties and, accordingly, Dendrite's actual results may differ significantly from the results discussed or implied in such forward-looking statements.
For more information, contact John E. Bailye, President & CEO, or George Robson, CFO, Dendrite International, Inc., 1200 Mt. Kemble Ave., Morristown, NJ 07960; Telephone: 201 425-1200. |
